Clinical Trials Directory

Trials / Unknown

UnknownNCT03396380

Effect of Vitamin D Supplement in Induction of Ovulation in Overweight Women With Polycystic Ovary Syndrome

Effect of Adding Vitamin D Supplement to Clomiphene Citrate for Induction of Ovulation in Overweight Women With Polycystic Ovary Syndrome

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
186 (estimated)
Sponsor
Ain Shams University · Academic / Other
Sex
Female
Age
25 Years – 35 Years
Healthy volunteers
Not accepted

Summary

The aim of this work is to evaluate the effect of vitamin D supplementation in overweight infertile women with PCOs undergoing induction of ovulation.

Detailed description

The study will include overweight infertile women with PCOS seeking fertility who will receive induction of ovulation by clomiphene citrate will be recruited and randomized into two groups: Group A (study group): 93 women who will receive clomiphene citrate for induction of ovulation with vitamin D and calcium supplement Group B (control group): 93 women who will receive clomiphene citrate for induction of ovulation with placebo and calcium supplement

Conditions

Interventions

TypeNameDescription
DRUGVitamin D with calcium and clomiphene citrate1. Vitamin D ( ossofortin®, EVA PHARMA) 10000 IU twice weekly and calcium (calciprex®, Marcyrl Pharmaceutical Industries ) 1250 mg twice daily which provide elemental calcium 500 mg/tablet for one month before induction of ovulation and both will be continued during the 3 induction cycles in the same regimen. 2. Induction of ovulation by clomiphene citrate (Clomid®, Aventis) 50 mg tablet twice daily 12 hours apart (total dose 100 mg daily) starting from the third day of menstrual cycle and for five days .
DRUGPlacebo Oral Tablet with calcium and clomiphene citrate1. The placebo tablet twice weekly and calcium (calciprex®, Marcyrl Pharmaceutical Industries ) 1250 mg twice daily which provide elemental calcium 500 mg/tablet for one month before induction of ovulation and both will be continued during the 3 induction cycles in the same regimen. 2. induction of ovulation by clomiphene citrate (Clomid®, Aventis) 50 mg tablet twice daily 12 hours apart (total dose 100 mg daily)starting from the 3rd day of menstrual cycle and for five days

Timeline

Start date
2017-07-01
Primary completion
2018-03-01
Completion
2018-05-01
First posted
2018-01-11
Last updated
2018-01-11

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03396380. Inclusion in this directory is not an endorsement.